ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0,26
0,00235
(0,91%)
Geschlossen 21 Dezember 10:00PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,26
Gebot
0,257
Fragen
0,269
Volumen
2.711.413
0,256 Tagesbereich 0,271
0,242 52-Wochen-Bereich 0,86
Marktkapitalisierung
Handelsende
0,25765
Handelsbeginn
0,26
Letzte Trade
1200
@
0.26
Letzter Handelszeitpunkt
Finanzvolumen
US$ 709.990
VWAP
0,261852
Durchschnittliches Volumen (3 Mio.)
2.224.586
Ausgegebene Aktien
1.297.445.623
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,43
Gewinn pro Aktie (EPS)
-0,05
Erlöse
1,93M
Nettogewinn
-64,37M

Über Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is i... Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Northwest Biotherapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NWBO. The last closing price for Northwest Biotherapeutics (QB) was US$0,26. Over the last year, Northwest Biotherapeutics (QB) shares have traded in a share price range of US$ 0,242 to US$ 0,86.

Northwest Biotherapeutics (QB) currently has 1.297.445.623 shares in issue. The market capitalisation of Northwest Biotherapeutics (QB) is US$334,29 million. Northwest Biotherapeutics (QB) has a price to earnings ratio (PE ratio) of -3.43.

NWBO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0401-13.36221259580.30010.31950.25635187110.26787713CS
4-0.025-8.771929824560.2850.31950.2527051380.27490205CS
12-0.0796-23.43934040050.33960.33960.24222245860.28304548CS
26-0.2092-44.58653026430.46920.4950.24222602110.32050228CS
52-0.45-63.38028169010.710.860.24220073140.41809104CS
156-0.37-58.73015873020.632.050.24221493270.67694948CS
2600.04520.93023255810.2152.540.00524337200.82901478CS

NWBO - Frequently Asked Questions (FAQ)

What is the current Northwest Biotherapeutics (QB) share price?
The current share price of Northwest Biotherapeutics (QB) is US$ 0,26
How many Northwest Biotherapeutics (QB) shares are in issue?
Northwest Biotherapeutics (QB) has 1.297.445.623 shares in issue
What is the market cap of Northwest Biotherapeutics (QB)?
The market capitalisation of Northwest Biotherapeutics (QB) is USD 334,29M
What is the 1 year trading range for Northwest Biotherapeutics (QB) share price?
Northwest Biotherapeutics (QB) has traded in the range of US$ 0,242 to US$ 0,86 during the past year
What is the PE ratio of Northwest Biotherapeutics (QB)?
The price to earnings ratio of Northwest Biotherapeutics (QB) is -3,43
What is the cash to sales ratio of Northwest Biotherapeutics (QB)?
The cash to sales ratio of Northwest Biotherapeutics (QB) is 113,33
What is the reporting currency for Northwest Biotherapeutics (QB)?
Northwest Biotherapeutics (QB) reports financial results in USD
What is the latest annual turnover for Northwest Biotherapeutics (QB)?
The latest annual turnover of Northwest Biotherapeutics (QB) is USD 1,93M
What is the latest annual profit for Northwest Biotherapeutics (QB)?
The latest annual profit of Northwest Biotherapeutics (QB) is USD -64,37M
What is the registered address of Northwest Biotherapeutics (QB)?
The registered address for Northwest Biotherapeutics (QB) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
Which industry sector does Northwest Biotherapeutics (QB) operate in?
Northwest Biotherapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0,10
(99.900,00%)
100
GNTLFGenetic Technologies Ltd (PK)
US$ 1,00
(90.809,09%)
100
VIVEViveve Medical Inc (CE)
US$ 0,0003
(29.900,00%)
7,33k
BTIMBoatim Inc (CE)
US$ 0,0002
(19.900,00%)
799
CLVRClever Leaves Holdings Inc (CE)
US$ 0,0002
(19.900,00%)
592
RAASYCloopen Group Holding Limited (CE)
US$ 0,000001
(-100,00%)
214
EWGFFEat Well Investment Group Inc (CE)
US$ 0,000001
(-100,00%)
47,01k
SOLBFSoLVBL Solutions Inc (CE)
US$ 0,000001
(-99,99%)
10k
HAVLFHavn Life Sciences Inc (CE)
US$ 0,000001
(-99,98%)
4,02k
ENDRFEndor AG (GM)
US$ 0,0001
(-99,98%)
560
HMBLHUMBL Inc (PK)
US$ 0,00095
(5,56%)
344,89M
PHILPHI Group Inc (PK)
US$ 0,0003
(0,00%)
312,21M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(0,00%)
215,71M
RDARRaadr Inc (PK)
US$ 0,0014
(16,67%)
174,96M
CHNVFChina Youzan Ltd (PK)
US$ 0,0177
(10,63%)
100M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock